{
  "page_number": 124,
  "text": " \n \n \ninvasive infections in neonates and children caused by Candida spp. Clin Microbiol Infect. 2012 \nDec;18 Suppl 7:38-52. doi: 10.1111/1469-0691.12040. PMID: 23137136. \n9. Bush K. (2001). New beta-lactamases in gram-negative bacteria: diversity and impact on the \nselection \nof \nantimicrobial \ntherapy. \nClin \nInfect \nDis, \n32(7), \n1085-1089. \nhttps://doi.org/10.1086/319610  \n10. Kimberlin, D. B., E.; Lynfield, R.; Sawyer, M. H. (2021). Antimicrobial Agents and Related \nTherapy. In Red Book: Report of the Committee on Infectious Diseases (32nd edition ed.). \nAmerican Academy of Pediatrics \n11. Rivera-Chaparro, N. D., Cohen-Wolkowiez, M., & Greenberg, R. G. (2017). Dosing antibiotics \nin neonates: review of the pharmacokinetic data. Future Microbiol, 12(11), 1001-1016. \nhttps://doi.org/10.2217/fmb-2017-0058  \n12. Shoji, K., Bradley, J. S., Reed, M. D., van den Anker, J. N., Domonoske, C., & Capparelli, E. V. \n(2016). Population Pharmacokinetic Assessment and Pharmacodynamic Implications of \nPediatric Cefepime Dosing for Susceptible-Dose-Dependent Organisms. Antimicrob Agents \nChemother, 60(4), 2150-2156. https://doi.org/10.1128/AAC.02592-15  \n13. Pichichero, M. E., & Casey, J. R. (2007). Safe use of selected cephalosporins in penicillin-allergic \npatients: \na \nmeta-analysis. \nOtolaryngol \nHead \nNeck \nSurg, \n136(3), \n340-347. \nhttps://doi.org/10.1016/j.otohns.2006.10.007  \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n",
  "tables": [],
  "italic_text": [
    "Clin",
    "Infect",
    "Dis",
    "Red Book: Report of the Committee on Infectious Diseases",
    "Future Microbiol",
    "Antimicrob Agents",
    "Chemother",
    "Otolaryngol",
    "Head",
    "Neck",
    "Surg",
    "136"
  ],
  "dimensions": {
    "width": 595.3200073242188,
    "height": 841.9199829101562
  }
}